lung
transplant
thought
repres
chronic
reject
increas
express
pentraxin
acut
phase
protein
associ
wors
outcom
lung
transplant
patient
determin
role
recipi
develop
chronic
reject
use
minor
alloantigenmismatch
murin
orthotop
singl
lung
transplant
model
male
mice
use
donor
male
knockout
ko
mice
wild
type
wt
litterm
background
use
recipi
ko
recipi
graft
lung
consolid
without
volum
recoveri
ct
scan
wt
mice
show
similar
graft
consolid
graft
lung
volum
could
reliabl
analyz
ct
scan
lung
volum
recoveri
significantli
reduc
ko
mice
compar
wt
interstiti
inflamm
parenchym
fibrosi
bronchiol
obliteran
score
significantli
higher
ko
mice
presenc
myofibroblast
lymphoid
aggreg
significantli
enhanc
graft
ko
recipi
recipi
defici
enhanc
chronic
rejectionlik
lesion
promot
fibrot
process
airway
lung
parenchyma
underli
mechan
potenti
protect
role
exogen
therapi
explor
chronic
lung
allograft
dysfunct
clad
incid
approxim
year
lung
transplant
biggest
impedi
longterm
surviv
damag
airway
epithelium
remodel
small
airway
fibrot
obliter
fibrosi
lung
parenchyma
major
patholog
featur
clad
chronic
reject
allogen
immun
responseinduc
lymphat
infiltr
lymphoid
tissu
format
lung
graft
consid
import
contribut
factor
increas
evid
suggest
inflamm
mediat
innat
immun
respons
ischemiareperfus
lung
allograft
activ
autoimmun
also
involv
pathogenesi
clad
exampl
primari
graft
dysfunct
pgd
acut
lung
injuri
first
h
lung
transplant
associ
develop
clad
identif
biomark
pgd
may
help
predict
possibl
prevent
pgd
well
clad
diamond
et
al
report
plasma
level
acut
phase
protein
significantli
increas
lung
transplant
associ
oncotarget
wwwimpactjournalscomoncotarget
develop
pgd
transplant
recipi
idiopath
pulmonari
fibrosi
ipf
copd
group
also
report
two
genet
variant
recipi
associ
develop
pgd
one
variant
associ
increas
plasma
level
chang
express
also
report
kidney
transplant
wherebi
express
posit
correl
degre
allograft
dysfunct
acut
renal
allograft
reject
import
inflammatori
mediat
critic
compon
humor
arm
innat
immun
solubl
pattern
recognit
receptor
immunostimulatori
immunoregulatori
function
orchestr
clearanc
pathogen
opson
damageand
pathogenassoci
molecular
pattern
regul
clearanc
apoptot
necrot
cell
prevent
autoimmun
patholog
elev
level
circul
follow
infect
tissu
damag
appear
predict
poor
patient
outcom
seen
patient
sepsi
acut
lung
injuri
hand
shown
provid
protect
specif
fungal
bacteri
viral
pathogen
follow
allogen
transplant
reactiv
latent
human
cytomegaloviru
major
caus
morbid
mortal
predispos
sever
complic
includ
superinfect
aspergillu
speci
murin
model
allogen
bone
marrow
transplant
treatment
induc
complet
resist
infect
reinfect
invas
aspergillosi
shown
bind
cytomegaloviru
protect
mice
primari
viral
infect
reactiv
well
aspergillu
superinfect
genet
defici
human
impair
antifung
capac
neutrophil
may
contribut
risk
invas
aspergillosi
patient
treat
hematopoiet
stemcel
transplant
function
solid
organ
transplant
howev
studi
present
studi
hypothes
endogen
recipientderiv
play
import
role
chronic
reject
pathogenesi
dampen
inflamm
fibrosi
lung
transplant
test
hypothesi
use
minormismatch
orthotop
lung
transplant
model
knockout
ko
mice
wild
type
wt
litterm
recipi
set
perform
left
lung
transplant
wt
ko
mice
three
ko
recipi
die
earli
lung
transplant
day
n
mice
found
hour
death
autopsi
identifi
caus
death
due
earli
mortal
lung
consolid
see
ko
mice
transplant
total
wt
ko
recipi
surviv
day
micro
ct
scan
use
monitor
allograft
graft
show
consolid
day
posttranspl
figur
wt
allograft
clear
day
figur
first
row
ko
allograft
remain
partial
figur
second
row
complet
figur
third
row
consolid
day
radiolog
appear
correl
gross
appear
lung
explant
lung
wt
recipi
soft
larger
lung
volum
recipi
show
shrunken
injur
graft
lung
figur
ct
scan
allograft
given
grade
reflect
sever
consolid
base
semiquantit
schema
ko
allograft
significantli
sever
consolid
persist
day
compar
wt
group
consolid
resolv
figur
quantit
assess
ct
scan
measur
actual
graft
volum
sinc
wt
graft
ko
graft
complet
consolid
could
distinguish
surround
soft
tissu
chest
wall
lung
volum
quantifi
remain
graft
comput
softwar
ko
group
show
trend
toward
lower
volum
compar
wt
group
even
though
differ
statist
signific
analyz
use
anova
figur
ask
question
whether
lung
volum
recoveri
differ
ko
wt
group
compar
lung
volum
day
baselin
wt
group
lung
volum
significantli
lower
day
compar
day
howev
volum
recov
day
figur
contrast
ko
group
volum
day
significantli
lower
day
figur
henc
even
exclus
sever
affect
allograft
ko
group
still
differ
lung
volum
recoveri
ko
wt
group
lung
allograft
histolog
assess
day
transplant
acut
reject
grade
accord
ishlt
guidelin
acut
reject
score
airway
inflamm
score
similar
wt
ko
group
figur
contrast
parenchym
fibrosi
assess
masson
trichrom
stain
significantli
higher
ko
group
figur
supplementari
figur
moreov
percentag
airway
affect
bo
significantli
higher
ko
oncotarget
wwwimpactjournalscomoncotarget
group
figur
furthermor
strong
correl
parenchym
fibrosi
airway
bo
figur
determin
whether
increas
fibrosi
relat
increas
number
myofibroblast
perform
immunofluoresc
stain
posit
cell
graft
exclud
posit
smooth
muscl
cell
around
vessel
airway
graft
ko
mice
posit
stain
myofibroblast
graft
wt
mice
figur
lymphoid
infiltr
aggreg
report
contribut
develop
clad
examin
lymphoid
aggreg
use
doubl
immunofluoresc
stain
stain
intens
analyz
ko
mice
significantli
larger
lymphoid
aggreg
lung
graft
wt
mice
figur
cell
posit
b
cell
posit
stain
also
significantli
higher
lung
graft
ko
mice
wt
mice
figur
neutrophil
macrophag
assess
lung
mice
day
post
transplant
immunofluoresc
stain
myeloperoxidas
respect
total
number
cell
identifi
dapi
stain
significantli
higher
ko
group
howev
number
neutrophil
macrophag
significantli
differ
ko
wt
group
supplementari
figur
assess
cytokin
chemokin
plasma
collect
day
use
multiplex
assay
exploratori
analysi
commerciallyavail
chosen
captur
common
cytokin
chemokin
previous
shown
involv
clad
bo
pathogenesi
among
cytokin
chemokin
analyz
detect
limit
oncotarget
wwwimpactjournalscomoncotarget
signific
differ
two
group
seen
term
plasma
figur
analyz
cytokin
chemokin
level
lung
graft
tissu
signific
differ
cytokin
analyz
includ
gcsf
gmcsf
supplementari
figur
similarli
signific
differ
cc
chemokin
supplementari
figur
cxc
chemokin
figur
examin
interestingli
howev
significantli
reduc
ko
mice
compar
wt
mice
figur
present
studi
use
ko
mice
demonstr
presenc
lung
transplant
recipi
play
protect
role
develop
chronic
rejectionlik
patholog
reduc
fibrot
lesion
small
airway
lung
parenchyma
may
mediat
inhibit
lymphocyt
infiltr
aggreg
lung
major
challeng
studi
mechan
develop
clad
lack
proper
anim
model
develop
mous
lung
transplant
model
signific
breakthrough
lung
transplant
research
allow
use
transgen
mice
mechanist
studi
fan
et
al
transplant
lung
b
mice
mice
identifi
bo
lesion
day
lung
transplant
recent
use
model
demonstr
mix
airway
parenchym
lesion
reminisc
patholog
chang
seen
clad
airway
bo
lesion
appear
good
correl
airway
fibrosi
seen
patient
bronchiol
obliteran
syndrom
addit
parenchym
fibrosi
reminisc
diffus
lung
diseas
seen
patient
restrict
allograft
syndrom
present
studi
use
b
mice
donor
recipi
progeni
mice
lesion
appear
sever
mice
use
recipi
transplant
lung
mice
result
acut
reject
bo
case
strain
express
allel
patholog
driven
immun
respons
direct
minor
alloantigen
avail
studi
mix
background
gener
hybrid
anim
mice
consequ
certain
oncotarget
wwwimpactjournalscomoncotarget
major
alloantigen
also
present
recipi
variabl
quantiti
suggest
may
variabl
degre
alloreact
recipi
recipi
may
explain
patholog
variabl
sever
lesion
histolog
section
despit
variat
defici
clearli
worsen
earli
radiograph
appear
allograft
day
patholog
cellular
infiltr
one
limit
present
studi
tissu
plasma
sampl
collect
end
day
studi
earlier
time
point
would
help
understand
role
earli
stage
develop
patholog
chang
howev
mous
lung
transplant
technic
challeng
protocol
requir
extens
train
practic
mous
avail
challeng
infertil
femal
result
initi
proofofprincipl
studi
use
one
time
point
tissu
collect
partial
compens
limit
use
microct
follow
chang
lung
volum
lung
appear
transplant
graft
ko
recipi
show
consolid
even
graft
without
complet
consolid
show
significantli
less
recoveri
lung
volum
microct
thu
provid
mean
monitor
statu
graft
longitudin
fashion
individu
anim
detail
morphometr
analys
microct
scan
may
valu
present
investig
major
histocompat
complex
mismatch
murin
lung
transplant
model
recent
develop
cross
haplotyp
mice
donor
mice
recipi
sinc
clinic
lung
transplant
major
antigen
mismatch
cladrel
studi
kind
model
consid
result
show
recipi
protect
develop
airway
parenchym
fibrosi
mention
earlier
plasma
level
lung
transplant
significantli
associ
develop
pgd
ipf
patient
copd
patient
similarli
ipf
clad
fibrot
oncotarget
wwwimpactjournalscomoncotarget
process
suggest
link
fibrosi
pathway
consist
clinic
studi
report
lack
associ
express
level
plasma
copd
inflammatori
rather
fibrot
process
signific
find
present
studi
reduct
featur
chronic
reject
seen
wt
recipi
reflect
less
lung
tissu
consolid
less
pulmonari
fibrosi
especi
occlus
airway
lesion
less
myofibroblast
lung
tissu
result
agreement
previou
studi
conduct
defici
mice
exampl
lack
aggrav
postischem
acut
kidney
injuri
follow
tubular
atrophi
interstiti
fibrosi
kidney
shrinkag
inject
recombin
h
reperfus
prevent
renal
leukocyt
recruit
postischem
kidney
injuri
treatment
acceler
recoveri
kidney
function
acut
injuri
reduc
collagen
express
posit
inhibit
interstiti
fibrosi
also
play
protect
role
cardiomyocyt
ischemia
reperfus
injuri
mice
show
exacerb
heart
damag
associ
greater
noreflow
area
increas
neutrophil
infiltr
decreas
number
capillari
increas
number
apoptot
cardiomyocyt
treatment
amelior
cardiomyocyt
apoptosi
infiltr
neutrophil
macrophag
improv
hemodynam
perform
recent
studi
suggest
produc
bone
marrowderiv
cell
play
crucial
role
cardiac
protect
myocardi
ir
injuri
attenu
infiltr
neutrophil
gener
ro
inflammatori
cytokin
mechan
may
help
explain
sever
fibrot
lesion
observ
defici
recipi
mous
lung
transplant
exogen
consid
therapeut
option
clad
futur
ko
recipi
dramat
lymphoid
aggreg
seen
graft
increas
number
cell
b
cell
lymphocyt
infiltr
consid
precursor
fibrou
obliter
lymphoid
neogenesi
found
anim
model
bo
well
patient
bo
clad
lung
transplant
increas
lymphoid
aggreg
graft
ko
mice
may
due
increas
lymphoid
infiltr
andor
neogenesi
lymphoid
tissu
merit
investig
find
differ
neutrophil
macrophag
lung
infiltr
ko
wt
group
day
posttranspl
increas
cellular
lung
tissu
therefor
mainli
due
lymphocyt
earlier
time
point
assess
futur
elucid
mechan
protect
explor
underli
mechan
measur
cytokin
chemokin
use
broad
multiplex
assay
circul
cytokin
chemokin
significantli
differ
ko
wt
recipi
contrast
lung
graft
ko
recipi
sever
cytokin
level
significantli
lower
wt
recipi
along
member
one
cytokin
famili
four
alpha
helix
bundl
molecular
structur
share
gamma
chain
receptor
signal
famili
cytokin
function
master
regul
influenc
cell
fate
decis
prime
differenti
help
maintain
differenti
state
interestingli
level
cytokin
promot
differenti
cytokin
also
reduc
allograft
ko
recipinet
chang
appear
specif
cytokin
chemokin
examin
show
signific
differ
promot
differenti
induc
promot
differenti
induc
specul
even
though
cell
b
cell
higher
allograft
ko
recipi
wt
anim
cell
may
differenti
clearli
investig
requir
understand
role
transplant
relat
cytokin
product
differenti
lymphocyt
graft
summari
produc
lung
allograft
recipi
may
help
regul
allograft
repair
prevent
fibrosi
airway
lung
tissu
prevent
lymphoid
aggreg
lung
graft
ampl
evid
anim
model
shown
exogen
administr
amelior
tissu
injuri
improv
organ
function
protect
role
endogen
demonstr
present
studi
suggest
therapeut
effect
exogen
merit
investig
mice
gener
breed
heterozyg
anim
background
dr
matzuk
baylor
colleg
medicin
mice
obtain
gener
anim
mice
genotyp
pcr
two
pair
primer
supplementari
tabl
design
murin
exon
human
hprt
contain
target
vector
supplementari
figur
exampl
pcr
genotyp
shown
supplementari
figur
male
mice
week
age
male
wt
litterm
use
recipi
lung
transplant
male
week
age
jackson
laboratori
bar
harbor
usa
maintain
standard
diet
kept
pathogenfre
environ
least
one
week
use
donor
mous
orthortop
lung
transplant
conduct
follow
techniqu
previous
describ
anim
receiv
care
complianc
guid
care
use
experiment
anim
formul
canadian
council
anim
care
anim
care
committe
toronto
gener
hospit
research
institut
approv
experiment
protocol
lung
transplant
recipi
mice
hous
pathogenfre
environ
maintain
standard
diet
without
antibiot
immunosuppress
euthan
day
lung
tissu
blood
sampl
collect
day
lung
transplant
mice
lightli
anesthet
isofluran
inhal
microcomput
tomographi
microct
taken
use
ge
locu
ultra
micro
ct
ge
healthcar
london
canada
anatom
scan
cover
whole
lung
allograft
appear
ct
scan
assign
grade
base
amount
consolid
clear
minim
consolid
mild
consolid
moder
consolid
sever
consolid
complet
consolid
lung
distinguish
surround
chest
wall
imag
outlin
lung
could
reliabl
defin
use
volumetr
analys
obtain
imag
analyz
use
microview
softwar
ge
healthcar
measur
lung
volum
use
follow
approach
outlin
lung
trace
approxim
section
apex
basal
portion
lung
region
softwar
gener
region
interest
interpol
manual
drawn
region
interest
reconstruct
volum
contain
lung
graft
lung
volum
calcul
measur
volum
region
interest
inferior
lung
allograft
clamp
cut
snapfrozen
liquid
nitrogen
preserv
later
protein
analysi
collect
rest
lung
tissu
left
atrium
cut
salin
inject
pulmonari
arteri
pa
lung
perfus
paraformaldehyd
inject
lung
intub
trachea
cmh
heart
lung
remov
enbloc
place
formalin
transfer
ethanol
lung
wwwimpactjournalscomoncotarget
graft
cut
part
upper
middl
lower
section
paraffinembed
section
use
hematoxylin
eosin
h
e
masson
trichrom
mt
stain
describ
previous
histolog
assess
perform
blind
fashion
acut
reject
grade
base
ishlt
criteria
parenchym
fibrosi
grade
percent
lung
tissu
affect
parenchym
fibrosi
estim
made
base
mt
slide
airway
bronchiol
obliteran
bo
assess
base
highpow
examin
mt
slide
airway
airway
affect
bo
count
within
part
upper
middl
lower
lung
sampl
percentag
airway
affect
bo
calcul
paraffinembed
tissu
section
deparaffin
antigen
retriev
perform
use
boil
citrat
buffer
ph
min
section
block
goat
serum
dako
serumfre
block
reagent
min
muscl
actin
stain
section
incub
overnight
antibodi
sigmaaldrich
oakvil
ontario
canada
wash
tween
section
counterstain
dapi
mount
slow
fade
mount
medium
invitrogen
waltham
usa
stain
section
incub
overnight
antibodi
dako
mississauga
ontario
canada
biotin
conjug
antibodi
bd
mississauga
ontario
canada
wash
section
incub
goat
antirabbit
igg
alexa
fluor
alexa
fluor
streptavidin
molecular
probe
eugen
dilut
antibodi
myeloperoxidas
mpo
abcam
cambridg
usa
use
neutrophil
macrophag
stain
respect
goat
antirabbit
igg
alexa
fluor
molecular
probe
eugen
usa
use
secondari
antibodi
dilut
section
counterstain
dapi
mount
lung
graft
describ
section
upper
middl
lower
part
stain
whole
area
section
assess
slide
digit
use
tissu
scope
confoc
fluoresc
slide
scanner
huron
technolog
waterloo
ontario
canada
um
per
pixel
resolut
computeraid
imag
analysi
perform
use
definien
tissu
studio
softwar
platform
definien
ag
munich
germani
softwar
first
use
segment
entir
lung
two
subregion
compos
lymphoid
aggreg
area
bulk
lung
tissu
base
presenc
posit
cell
lymphoid
aggreg
follow
cellular
segment
perform
base
presenc
dapi
signal
use
identifi
cell
lymphoid
aggreg
lung
region
interest
threshold
posit
stain
set
observ
true
posit
cell
present
lymphoid
aggreg
background
lung
tissu
three
threshold
set
classifi
posit
cell
high
middl
low
neg
stain
high
stain
indic
robustli
posit
cell
medium
stain
indic
posit
stain
cell
low
indic
margin
degre
stain
reach
threshold
true
posit
machinelearn
analyt
techniqu
precis
manual
cell
count
describ
previous
high
middl
intens
posit
cell
sum
divid
whole
lung
cell
number
area
counterstain
dapi
calcul
percentag
posit
cell
posit
cell
quantif
posit
cell
includ
vascular
airway
smooth
muscl
cell
myofibroblast
posit
stain
analyz
definien
tissuestudio
posit
stain
around
vessel
bronchi
exclud
analysi
focu
primarili
myofibroblast
lung
tissu
vascular
airway
smooth
muscl
analysi
myofibroblast
signal
assess
time
perpixel
basi
threshold
identifi
high
medium
low
neg
signal
stain
intens
posit
area
assess
count
region
posit
class
signal
shown
screenshot
red
repres
high
yellow
high
white
medium
intens
three
intens
signal
includ
posit
stain
posit
pixel
count
mm
total
lung
area
mm
x
six
sampl
ko
wt
group
avail
quantif
macrophag
neutrophil
six
field
per
mous
randomli
chosen
field
consist
x
stitch
field
captur
magnif
confoc
microscop
number
mpo
posit
cell
dapistain
nuclei
count
use
imagej
ver
nation
institut
health
bethesda
md
usa
averag
number
cell
per
highpowerfield
quantifi
blood
collect
time
necropsi
inferior
vena
cava
place
heparin
tube
centrifug
min
plasma
store
analysi
cytokin
chemokin
